✓Strengths
- Moderate debt: debt-to-equity of 0.53.
- Comfortable interest cover: operating profit covers interest about 66.1 times.
- Return on equity is healthy at 20.6%.
- Return on capital employed is healthy at 21.5%.
- Net profit margin is strong at 15.9%.
- Current assets comfortably cover current liabilities (current ratio 3.29).
- Profit has compounded about 75% a year over five years.
- Sales have compounded about 15% a year over five years.
- Has paid a dividend in each of the last 4 years on record.
!Watch-points
No notable watch-points flagged by the automated checks.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreGrey zone
2.68
This middle range was less conclusive in Altman’s study — neither clearly safe nor clearly distressed.
Computed without the market-value term.
Piotroski F-ScoreWeak
2 / 5
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 5 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Current Price¥ 1,103.00
High / Low¥ 1,110.00 / 694.00
Book Value¥ 380.42
ROCE21.49%
ROE20.60%
Debt to Equity0.53
Current Ratio3.29
EPS¥ 72.50
PAT Margin15.86%
ICR66.09
Compounded Sales Growth
10 Years
—
5 Years
14.73%
3 Years
—
TTM
—
Compounded Profit Growth
10 Years
—
5 Years
74.99%
3 Years
—
TTM
—
Stock Price CAGR
10 Years
—
5 Years
—
3 Years
—
1 Year
—
Return on Equity
10 Years
—
5 Years
—
3 Years
—
Last Year
20.60%